# SRC and ERK Regulate the Turnover of Cytoskeletal Keratin Filaments

**Authors:** Marcin Moch, Rudolf E. Leube

PMC · DOI: 10.3390/ijms26125476 · International Journal of Molecular Sciences · 2025-06-07

## TL;DR

This study shows that the proteins SRC and ERK control how keratin filaments in epithelial cells break down and reorganize, which is important for cell function and response to signals.

## Contribution

The study identifies SRC and ERK as key regulators of keratin filament turnover, extending beyond EGF signaling.

## Key findings

- SRC and ERK kinases regulate keratin filament turnover in epithelial cells.
- PI3K/AKT and FAK have little to no effect on keratin filament turnover.
- SRC and ERK are activated by multiple signals and stresses, not just EGF.

## Abstract

Epithelial differentiation and function are tightly coupled to the keratin intermediate filament cytoskeleton. Keratin filaments are unique among the cytoskeletal filament systems in terms of biochemical properties, diversity and turnover mechanisms supporting epithelial plasticity in response to a multitude of environmental cues. Epidermal growth factor (EGF) is such a cue. It is not only intricately intertwined with epithelial physiology but also modulates keratin filament network organization by increasing keratin filament turnover. The involved EGF receptor (EGFR)-dependent intracellular signaling cascades, however, have not been identified to date. We therefore tested the effect of selective inhibitors of downstream effectors of the EGFR on keratin filament turnover using quantitative fluorescence recovery after photobleaching experiments as readouts. We find that SRC and ERK kinases are involved in the regulation of keratin filament turnover, whereas PI3K/AKT and FAK have little or no effect. The identification of SRC and ERK as major keratin filament regulators extends beyond EGF signaling since they are also activated by other signals and stresses. Our data unveil a mechanism that allows modification of the properties of keratin filaments at very high temporal and spatial acuity.

## Linked entities

- **Genes:** SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714], EPHB2 (EPH receptor B2) [NCBI Gene 2048], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747], EGFR (epidermal growth factor receptor) [NCBI Gene 1956]
- **Chemicals:** EGF (PubChem CID 7276368)

## Full-text entities

- **Genes:** EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, PTK2 (protein tyrosine kinase 2) [NCBI Gene 5747] {aka FADK, FADK 1, FAK, FAK1, FRNK, PPP1R71}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193469/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12193469/full.md

## References

108 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193469/full.md

---
Source: https://tomesphere.com/paper/PMC12193469